Pathological Controversies in Breast Cancer: Classification of Ductal Carcinoma In Situ , Sentinel Lymph Nodes and Low Volume Metastatic Disease and Reporting of Neoadjuvant Chemotherapy Specimens

• Published in: Clinical oncology (Royal College of Radiologists (Great Britain)) Vol. 25; no. 2; pp. 80 - 92
• Main Authors: Provenzano, E, Brown, J.P, Pinder, S.E
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.02.2013
• Subjects: Breast cancer; Breast Neoplasms - classification; Breast Neoplasms - drug therapy; Breast Neoplasms - genetics; Breast Neoplasms - pathology; Carcinoma in Situ - classification; Carcinoma in Situ - drug therapy; Carcinoma in Situ - genetics; Carcinoma in Situ - pathology; Carcinoma, Ductal - classification; Carcinoma, Ductal - drug therapy; Carcinoma, Ductal - genetics; Carcinoma, Ductal - pathology; Carcinoma, Ductal, Breast - classification; Carcinoma, Ductal, Breast - drug therapy; Carcinoma, Ductal, Breast - genetics; Carcinoma, Ductal, Breast - pathology; Chemotherapy, Adjuvant; ductal carcinoma in situ; Female; Hematology, Oncology and Palliative Medicine; histopathology; Humans; Lymph Nodes - pathology; Lymphatic Metastasis; neoadjuvant chemotherapy; Neoadjuvant Therapy; Radiology; Sentinel Lymph Node Biopsy; sentinel lymph nodes; ductal carcinoma in situ; histopathology; neoadjuvant chemotherapy; Breast cancer; sentinel lymph nodes

Abstract The pathological classification of breast cancer is constantly being updated to reflect the advances in our clinical and biological understanding of the disease. This overview examines new insights into the classification and molecular biology of ductal carcinoma in situ , the pathological...